Literature DB >> 1312987

Three different patterns of hepatitis C virus infection in chimpanzees.

K Abe1, G Inchauspe, T Shikata, A M Prince.   

Abstract

The relationship between hepatitis C virus RNA and hepatitis C virus-associated antibodies (antibody against the putative capsid protein and C-100 antibody) was determined by nested polymerase chain reaction and enzyme-linked immunosorbent assay in serial serum samples obtained from eight chimpanzees experimentally infected with hepatitis C virus. Three different patterns emerged from the polymerase chain reaction data: the first (group 1) was acute resolving hepatitis with transient appearance of HCV RNA (two cases). The second (group 2) had chronic hepatitis with persistent hepatitis C virus RNA positivity (four cases) and the third (group 3) had chronic hepatitis with intermittent appearance of hepatitis C virus RNA (two cases). In four of eight animals, hepatitis C virus RNA was first detectable in serum 1 wk after inoculation. Although serum HCV RNA was detected in all infected chimpanzees, two were positive only for antibody against the putative capsid protein, whereas two were positive only for antibody to C-100 antigen. In four of eight cases, antibody against the putative capsid protein appeared earlier than did antibody to C-100 antigen, was detected just before or coincident with rising glutamate pyruvate transaminase values and remained positive for a long time even after recovery. Six of eight animals (75%) were still hepatitis C virus RNA positive 1 yr after inoculation, suggesting that the risk of development of the chronic carrier state is high in hepatitis C virus infection. Furthermore, there did not appear to be a good correlation between antibody titer in serum and hepatitis C virus infectivity titer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312987     DOI: 10.1002/hep.1840150423

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.

Authors:  Mohamed Tarek Shata; Nancy Tricoche; Marion Perkus; Darley Tom; Betsy Brotman; Patricia McCormack; Wolfram Pfahler; Dong-Hun Lee; Leslie H Tobler; Michael Busch; Alfred M Prince
Journal:  Virology       Date:  2003-09-30       Impact factor: 3.616

2.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Authors:  Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

Review 3.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

4.  Detection of hepatitis C virus RNA using ligation-dependent polymerase chain reaction in formalin-fixed, paraffin-embedded liver tissues.

Authors:  Y N Park; K Abe; H Li; T Hsuih; S N Thung; D Y Zhang
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

5.  [Study of HCV infection and viremia in patients with posttransfusion hepatitis in China].

Authors:  Z Y Tang; D L Yang; Z Q Yu; L J Hao
Journal:  J Tongji Med Univ       Date:  1995

6.  Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection.

Authors:  J M Jacobson; L Feinman; L Liebes; N Ostrow; V Koslowski; A Tobia; B E Cabana; D Lee; J Spritzler; A M Prince
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

7.  GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.

Authors:  E Scarselli; A Urbani; A Sbardellati; L Tomei; R De Francesco; C Traboni
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Hepatitis C markers in hemodialysis patients.

Authors:  C S Huang; M S Ho; C S Yang; C L Lee; C A Tan
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.

Authors:  S E Bassett; D L Thomas; K M Brasky; R E Lanford
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.